Suppr超能文献

[口腔进展性鳞状细胞癌的原发性细胞抑制疗法]

[Primary cytostatic therapy of progressive squamous cell carcinoma of the oral cavity].

作者信息

Bienengräber V

出版信息

Arch Geschwulstforsch. 1986;56(5):353-6.

PMID:2429630
Abstract

Reported on therapeutic study by 20 patients with inoperable carcinoma of the oral cavity. Primary we made a systemic antineoplastic chemotherapy with combination of methotrexate, bleomycine and vincristine. After the cytostatic therapy we lead through an operative revision or a radiological treatment. The patients live on an average 11.5 months. This is not longer than in the control-group with solitary radiological treatment. At present we cannot recommend the neoadjuvant chemotherapy of progressive squamous cell carcinomas of the oral cavity.

摘要

报告了20例口腔无法手术切除的癌患者的治疗研究。首先,我们采用甲氨蝶呤、博来霉素和长春新碱联合进行全身抗肿瘤化疗。在细胞抑制治疗后,我们进行手术修正或放射治疗。患者平均存活11.5个月。这并不比单纯接受放射治疗的对照组更长。目前,我们不推荐对进展期口腔鳞状细胞癌进行新辅助化疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验